Insights

Strategic Focus Lite Strategy positions itself as the leading Litecoin treasury vehicle with a mission to increase LTC exposure for shareholders, presenting a potential selling point for services around digital asset treasury management, custody, and compliance solutions tailored to crypto-focused funds.

Financial Scale With reported revenue in the hundreds of millions and substantial funding, there is an opportunity to offer enterprise-grade fintech and data analytics, liquidity management, and risk monitoring tools that align with a high-capital, crypto-native investment approach.

Technology Stack The use of industry-standard tools like MySQL, Highcharts, DocuSign, Cloudflare services, and Adobe Experience Cloud indicates a mature digital operations footprint, suggesting upsell opportunities in data visualization, secure API integrations, and marketing automation for investor communications.

Industry Partnerships Active participation in crypto-focused events such as the Litecoin Foundation Summit and investments in Layer-2 infrastructure (LitVM) signal openness to collaborations, ecosystem tooling, and strategic partnerships that could be leveraged for joint ventures, co-marketed solutions, or consulting services.

Global Growth The company’s public listing (NASDAQ: LITS) and international engagement imply a need for scalable regulatory, compliance, and reporting platforms, as well as multilingual investor relations services to support continued expansion and transparency for shareholders.

Lite Strategy (formerly MEI Pharma) Tech Stack

Lite Strategy (formerly MEI Pharma) uses 8 technology products and services including Site Kit, Adobe Experience Cloud, MySQL, and more. Explore Lite Strategy (formerly MEI Pharma)'s tech stack below.

  • Site Kit
    Analytics
  • Adobe Experience Cloud
    Data Management Platforms
  • MySQL
    Database
  • Cloudflare DNS
    Domain Name Services
  • Highcharts
    Javascript Graphics
  • DocuSign
    Miscellaneous
  • reCAPTCHA
    Security
  • Cloudflare Bot Management
    Security

Lite Strategy (formerly MEI Pharma)'s Email Address Formats

Lite Strategy (formerly MEI Pharma) uses at least 2 format(s):
Lite Strategy (formerly MEI Pharma) Email FormatsExamplePercentage
FLast@meipharma.comJDoe@meipharma.com
73%
Last@meipharma.comDoe@meipharma.com
16%
First@meipharma.comJohn@meipharma.com
10%
First.Last@meipharma.comJohn.Doe@meipharma.com
1%
FLast@litestrategy.comJDoe@litestrategy.com
100%

Frequently Asked Questions

What is Lite Strategy (formerly MEI Pharma)'s phone number?

Minus sign iconPlus sign icon
You can contact Lite Strategy (formerly MEI Pharma)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Lite Strategy (formerly MEI Pharma)'s stock symbol?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma) is a publicly traded company; the company's stock symbol is MEIP.

What is Lite Strategy (formerly MEI Pharma)'s official website and social media links?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma)'s official website is litestrategy.com and has social profiles on LinkedInCrunchbase.

What is Lite Strategy (formerly MEI Pharma)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma)'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Lite Strategy (formerly MEI Pharma) have currently?

Minus sign iconPlus sign icon
As of July 2026, Lite Strategy (formerly MEI Pharma) has approximately 111 employees across 4 continents, including North AmericaAsiaEurope. Key team members include President & Chief Executive Officer: D. G.Executive Vice President Finance: J. F.Director, Drug Safety And Pharmacovigilance: M. W.. Explore Lite Strategy (formerly MEI Pharma)'s employee directory with LeadIQ.

What industry does Lite Strategy (formerly MEI Pharma) belong to?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma) operates in the Biotechnology Research industry.

What technology does Lite Strategy (formerly MEI Pharma) use?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma)'s tech stack includes Site KitAdobe Experience CloudMySQLCloudflare DNSHighchartsDocuSignreCAPTCHACloudflare Bot Management.

What is Lite Strategy (formerly MEI Pharma)'s email format?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma)'s email format typically follows the pattern of FLast@meipharma.com. Find more Lite Strategy (formerly MEI Pharma) email formats with LeadIQ.

How much funding has Lite Strategy (formerly MEI Pharma) raised to date?

Minus sign iconPlus sign icon
As of July 2026, Lite Strategy (formerly MEI Pharma) has raised $260M in funding. The last funding round occurred on Jul 18, 2025 for $100M.

When was Lite Strategy (formerly MEI Pharma) founded?

Minus sign iconPlus sign icon
Lite Strategy (formerly MEI Pharma) was founded in 2000.
Lite Strategy (formerly MEI Pharma) logo

Lite Strategy (formerly MEI Pharma)

Biotechnology ResearchCalifornia, United States51-200 Employees

MEI Pharma is a biotechnology research company based in San Diego, California, at 11455 el Camino Real Suite 250. The company is described as employing 51-200 people. The listed website for the entity is https://litestrategy.com. There is no information provided on MEI Pharma's specific products, clinical programs, or services. The data set also includes references to Lite Strategy (LITS) and Litecoin-related activities that appear unrelated to MEI Pharma.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
MEIP
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
51-200

Section iconFunding & Financials

  • $260M

    Lite Strategy (formerly MEI Pharma) has raised a total of $260M of funding over 6 rounds. Their latest funding round was raised on Jul 18, 2025 in the amount of $100Mas a post_ipo_equity.

  • $250M$500M

    Lite Strategy (formerly MEI Pharma)'s revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $260M

    Lite Strategy (formerly MEI Pharma) has raised a total of $260M of funding over 6 rounds. Their latest funding round was raised on Jul 18, 2025 in the amount of $100Mas a post_ipo_equity.

  • $250M$500M

    Lite Strategy (formerly MEI Pharma)'s revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.